Tenaya Therapeutics (TNYA) Return on Capital Employed (2021 - 2026)
Tenaya Therapeutics' (TNYA) quarterly Return on Capital Employed came in at 69.12% in Q1 2026, up 2403.0% year-on-year from 2.76% in Q1 2025, and up 18.15% quarter-over-quarter from 84.45% in Q4 2025.
Tenaya Therapeutics (TNYA) Return on Capital Employed (2021 - 2026) Analysis & Trends
Tenaya Therapeutics' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 69.12% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 2403.0% year-over-year to 69.12% in Q1 2026; TTM through Mar 2026 was 69.12%, a 2403.0% increase from a year earlier, with the FY2025 full-year figure at 79.1%, up 1061.0% from the prior year.
- Return on Capital Employed grew to 69.12% in Q1 2026 per TNYA's latest filing, from 84.45% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 32.59% in Q1 2022 and bottomed at 101.45% in Q4 2024.
- The 5-year median for Return on Capital Employed is 80.69% (2024), against an average of 72.73%.
- Across the five-year window, Return on Capital Employed plunged 3083 bps in 2022 and surged 2403 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 55.01% in 2022, then tumbled by 50 bps to 82.4% in 2023, then fell by 23 bps to 101.45% in 2024, then increased by 17 bps to 84.45% in 2025, then grew by 18 bps to 69.12% in 2026.
- Per Business Quant, the three latest TNYA Return on Capital Employed figures stand at 69.12% (Q1 2026), 84.45% (Q4 2025), and 96.86% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Tenaya Therapeutics | 167.00 Mn | 167.00 Mn | - | -69.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.12% |
| Dec 31, 2025 | -84.45% |
| Sep 30, 2025 | -96.86% |
| Jun 30, 2025 | -85.54% |
| Mar 31, 2025 | -93.15% |
| Dec 31, 2024 | -101.45% |
| Sep 30, 2024 | -90.45% |
| Jun 30, 2024 | -80.69% |
| Mar 31, 2024 | -82.77% |
| Dec 31, 2023 | -82.40% |
| Sep 30, 2023 | -71.55% |
| Jun 30, 2023 | -63.49% |
| Mar 31, 2023 | -52.79% |
| Dec 31, 2022 | -55.01% |
| Sep 30, 2022 | -52.48% |
| Jun 30, 2022 | -41.70% |
| Mar 31, 2022 | -32.59% |
| Dec 31, 2021 | -24.17% |
| Sep 30, 2021 | -24.70% |